FR2255883B1 - - Google Patents

Info

Publication number
FR2255883B1
FR2255883B1 FR7346740A FR7346740A FR2255883B1 FR 2255883 B1 FR2255883 B1 FR 2255883B1 FR 7346740 A FR7346740 A FR 7346740A FR 7346740 A FR7346740 A FR 7346740A FR 2255883 B1 FR2255883 B1 FR 2255883B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7346740A
Other languages
French (fr)
Other versions
FR2255883A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE ETD IND PHARMA
Centre dEtudes pour lIndustrie Pharmaceutique
Original Assignee
CENTRE ETD IND PHARMA
Centre dEtudes pour lIndustrie Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTRE ETD IND PHARMA, Centre dEtudes pour lIndustrie Pharmaceutique filed Critical CENTRE ETD IND PHARMA
Priority to FR7346740A priority Critical patent/FR2255883A1/en
Publication of FR2255883A1 publication Critical patent/FR2255883A1/en
Application granted granted Critical
Publication of FR2255883B1 publication Critical patent/FR2255883B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
FR7346740A 1973-12-28 1973-12-28 Clofibric acid-vitamin B6 compsns. - with synergistic hypocholesterolaemic and normolipaemic activity Granted FR2255883A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7346740A FR2255883A1 (en) 1973-12-28 1973-12-28 Clofibric acid-vitamin B6 compsns. - with synergistic hypocholesterolaemic and normolipaemic activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7346740A FR2255883A1 (en) 1973-12-28 1973-12-28 Clofibric acid-vitamin B6 compsns. - with synergistic hypocholesterolaemic and normolipaemic activity

Publications (2)

Publication Number Publication Date
FR2255883A1 FR2255883A1 (en) 1975-07-25
FR2255883B1 true FR2255883B1 (en) 1977-07-08

Family

ID=9129850

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7346740A Granted FR2255883A1 (en) 1973-12-28 1973-12-28 Clofibric acid-vitamin B6 compsns. - with synergistic hypocholesterolaemic and normolipaemic activity

Country Status (1)

Country Link
FR (1) FR2255883A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288716A (en) * 1987-02-18 1994-02-22 Ulrich Speck Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
JP2002539127A (en) 1999-03-08 2002-11-19 メディキュア インコーポレーテッド Pyridoxal analogs for vitamin B-6 disorders
WO2001003682A2 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
JP2003507418A (en) 1999-08-24 2003-02-25 メディキュア インターナショナル インコーポレイテッド Treatment of cardiovascular disease and related diseases
PT1268498E (en) 2000-02-29 2005-07-29 Medicure Int Inc CARDIOPROTECTOR PHOSPHONATES
WO2001072309A2 (en) 2000-03-28 2001-10-04 Medicure International Inc. Treatment of cerebrovascular disease
EP1299358B1 (en) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
FR2255883A1 (en) 1975-07-25

Similar Documents

Publication Publication Date Title
AU476761B2 (en)
AR201231Q (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU476714B2 (en)
FR2255883B1 (en)
AR201229Q (en)
AU476696B2 (en)
AU472848B2 (en)
AR199451A1 (en)
AU477823B2 (en)
AU477824B2 (en)
AR193950A1 (en)
AR200885A1 (en)
AR195948A1 (en)
AU476873B1 (en)
AR196382A1 (en)
AR197627A1 (en)
AR200256A1 (en)
AR195311A1 (en)
AR196123Q (en)
AR196212Q (en)
AU479420A (en)
BG19613A1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse